Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1996-03-21
2000-02-29
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 43, A01N 4304, A61K 31705
Patent
active
060309555
ABSTRACT:
The present invention provides methods of stimulating or inhibiting intracellular phosphorylation of tyrosine by a heparin-binding receptor which comprises contacting a cell having on its surface the heparin-binding receptor with a phosphorothioate oligonucleotide moiety of suitable length and base composition, such phosphorothioate oligonucleotide moiety being present in an effective amount. The invention further provides a method of inhibiting the formation of blood vessels in a subject which comprises administering to the subject an amount of a phosphorothioate oligonucleotide moiety of suitable length and base composition. The invention also provides a method of inhibiting proliferation of cells having a malignant phenotype in a subject which comprises administering to the subject an amount of a phosphorothioate oligonucleotide moiety of suitable length and base composition.
REFERENCES:
Abstract to Sakano et al. of JP 94-320712, Dec. 22, 1994.
Stedman's Medical Dictionary, 24th Edition, pp. 777 and 1254, Feb. 1983.
Guvakova, M.A., et al., "Phosphorothioate Oligodeoxynucleotides Bind to Basic Fibroblast Growth Factor, Inhibit Its Binding to Cell Surface Receptors, and Remove It from Low Affinity Binding Sites on Extracellular Matrix." J. Biol. Chem. 270: 2620-2627 (1995).
Khalad, Z., et al., "Effects of Suramin-related and Other Clinically Therapeutic Polyanions on Protein Kinase C Activity.sup.1." Clin. Cancer Res. 1: 113-122 (1995).
Millauer, B., et al., "Glioblastoma growth inhibited in vivo by a dominant-negative F1k-1 mutant." Nature (Lond) 367: 576-579 (1994).
Yakubov, L., et al., "Oligodeoxynucleotides Interact with Recombinant CD4 at Multiple Sites*." J. Biol. Chem. 268: 18818-18823 (1993).
Rockwell Patricia
Stein Cy
Henley III Raymond
Jones Dwayne C.
The Trustees of Columbia University in The City of New York and
White John P.
LandOfFree
Methods of affecting intracellular phosphorylation of tyrosine u does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of affecting intracellular phosphorylation of tyrosine u, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of affecting intracellular phosphorylation of tyrosine u will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-683093